Research ExplorerScientific StaffBarbara Schmalfeldt Publications

Prof.Dr.med. ID: 2373005

Barbara Schmalfeldt

graph of relations
Affiliations
101 - 150 out of 193Page size: 50

Publications

  1. 2016

  2. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer

    Bronger, H., Singer, J., Windmüller, C., Reuning, U., Zech, D., Delbridge, C., Dorn, J., Kiechle, M., Schmalfeldt, B., Schmitt, M. & Avril, S., 23.08.2016, In: BRIT J CANCER. 115, 5, p. 553-63 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node

    Woelber, L., Eulenburg, C., Grimm, D., Trillsch, F., Bohlmann, I., Burandt, E., Dieckmann, J., Klutmann, S., Schmalfeldt, B., Mahner, S. & Prieske, K., 08.2016, In: ANN SURG ONCOL. 23, 8, p. 2508-14

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium

    Cannioto, R., LaMonte, M. J., Risch, H. A., Hong, C-C., Sucheston-Campbell, L. E., Eng, K. H., Brian Szender, J., Chang-Claude, J., Schmalfeldt, B., Klapdor, R., Gower, E., Minlikeeva, A. N., Zirpoli, G. R., Bandera, E. V., Berchuck, A., Cramer, D., Doherty, J. A., Edwards, R. P., Fridley, B. L., Goode, E. L., Goodman, M. T., Hogdall, E., Hosono, S., Jensen, A., Jordan, S., Kjaer, S. K., Matsuo, K., Ness, R. B., Olsen, C. M., Olson, S. H., Leigh Pearce, C., Pike, M. C., Anne Rossing, M., Szamreta, E. A., Thompson, P. J., Tseng, C-C., Vierkant, R. A., Webb, P. M., Wentzensen, N., Wicklund, K. G., Winham, S. J., Wu, A. H., Modugno, F., Schildkraut, J. M., Terry, K. L., Kelemen, L. E., Moysich, K. B. & Australian Ovarian Cancer Study, 07.2016, In: CANCER EPIDEM BIOMAR. 25, 7, p. 1114-24 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium

    Cannioto, R. A., LaMonte, M. J., Kelemen, L. E., Risch, H. A., Eng, K. H., Minlikeeva, A. N., Hong, C-C., Szender, J. B., Sucheston-Campbell, L., Joseph, J. M., Berchuck, A., Chang-Claude, J., Cramer, D. W., DeFazio, A., Diergaarde, B., Dörk, T., Doherty, J. A., Edwards, R. P., Fridley, B. L., Friel, G., Goode, E. L., Goodman, M. T., Hillemanns, P., Hogdall, E., Hosono, S., Kelley, J. L., Kjaer, S. K., Klapdor, R., Matsuo, K., Odunsi, K., Nagle, C. M., Olsen, C. M., Paddock, L. E., Pearce, C. L., Pike, M. C., Rossing, M. A., Schmalfeldt, B., Segal, B. H., Szamreta, E. A., Thompson, P. J., Tseng, C-C., Vierkant, R., Schildkraut, J. M., Wentzensen, N., Wicklund, K. G., Winham, S. J., Wu, A. H., Modugno, F., Ness, R. B., Jensen, A., Webb, P. M., Terry, K., Bandera, E. V. & Moysich, K. B., 14.06.2016, In: BRIT J CANCER. 115, 1, p. 95-101

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer

    Claussen, C., Rausch, A-V., Lezius, S., Amirkhosravi, A., Davila, M., Francis, J. L., Hisada, Y. M., Mackman, N., Bokemeyer, C., Schmalfeldt, B., Mahner, S. & Langer, F., 02.03.2016, In: THROMB RES. 141, p. 39-48 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)

    Emons, G., Kurzeder, C., Schmalfeldt, B., Neuser, P., de Gregorio, N., Pfisterer, J., Park-Simon, T-W., Mahner, S., Schröder, W., Lück, H-J., Heubner, M. L., Hanker, L., Thiel, F. & Hilpert, F., 03.2016, In: GYNECOL ONCOL. 140, 3, p. 450-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome

    Dorn, J., Yassouridis, A., Walch, A., Diamandis, E. P., Schmitt, M., Kiechle, M., Wang, P., Drecoll, E., Schmalfeldt, B., Loessner, D., Kotzsch, M. & Magdolen, V., 2016, In: AM J CANCER RES. 6, 1, p. 61-70 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2015

  10. The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients

    Bachmann, H. S., Meier, W., du Bois, A., Kimmig, R., Kuhlmann, J. D., Siffert, W., Sehouli, J., Wollschlaeger, K., Huober, J., Hillemanns, P., Burges, A., Schmalfeldt, B., Aminossadati, B. & Wimberger, P., 11.2015, In: BRIT J CLIN PHARMACO. 80, 5, p. 1139-48 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study

    Fotopoulou, C., Sehouli, J., Ewald-Riegler, N., de Gregorio, N., Reuss, A., Richter, R., Mahner, S., Kommoss, F., Schmalfeldt, B., Fehm, T., Hanker, L., Wimberger, P., Canzler, U., Pfisterer, J., Kommoss, S., Hauptmann, S., du Bois, A. & ROBOT investigators, 09.2015, In: INT J GYNECOL CANCER. 25, 7, p. 1248-52 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO

    Pölcher, M., Hauptmann, S., Fotopoulou, C., Schmalfeldt, B., Meinhold-Heerlein, I., Mustea, A., Runnebaum, I. & Sehouli, J., 07.2015, In: ARCH GYNECOL OBSTET. 292, 1, p. 231-4 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO Ovar

    Pölcher, M., Hauptmann, S., Fotopoulou, C., Schmalfeldt, B., Meinhold-Heerlein, I., Mustea, A., Runnebaum, I., Sehouli, J. & Kommission Ovar of the Gynecologic Oncology Study Group (AGO), 04.2015, In: GEBURTSH FRAUENHEILK. 75, 4, p. 339-341 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Oza, A. M., Cibula, D., Benzaquen, A. O., Poole, C., Mathijssen, R. H. J., Sonke, G. S., Colombo, N., Špaček, J., Vuylsteke, P., Hirte, H., Mahner, S., Plante, M., Schmalfeldt, B., Mackay, H., Rowbottom, J., Lowe, E. S., Dougherty, B., Barrett, J. C. & Friedlander, M., 01.2015, In: LANCET ONCOL. 16, 1, p. 87-97 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery

    Dorn, J., Bronger, H., Kates, R., Slotta-Huspenina, J., Schmalfeldt, B., Kiechle, M., Diamandis, E. P., Soosaipillai, A., Schmitt, M. & Harbeck, N., 01.2015, In: ONCOL LETT. 9, 1, p. 418-424 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. 2014

  17. Aktuelles zur Therapie des Ovarialkarzinoms

    Schmalfeldt, B., 2014, Tumorzentrum München Jahrbuch 2014. . München: Agileum Verlag und Gesundheitsakademie GmbH

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  18. Manual Maligne Ovarialtumoren. Empfehlungen zu Diagnostik, Therapie und Nachsorge.

    Schmalfeldt, B., 2014, München: W. Zuckschwerdt Verlag.

    Research output: Book/anthology › Collected edition/anthology

  19. 2013

  20. High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells

    Volkmann, J., Reuning, U., Rudelius, M., Häfner, N., Schuster, T., Becker V Ros, A., Weimer, J., Hilpert, F., Kiechle, M., Dürst, M., Arnold, N., Schmalfeldt, B., Meindl, A. & Ramser, J., 15.06.2013, In: INT J CANCER. 132, 12, p. 2820-32 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study

    Sabbatini, P., Harter, P., Scambia, G., Sehouli, J., Meier, W., Wimberger, P., Baumann, K. H., Kurzeder, C., Schmalfeldt, B., Cibula, D., Bidzinski, M., Casado, A., Martoni, A., Colombo, N., Holloway, R. W., Selvaggi, L., Li, A., del Campo, J., Cwiertka, K., Pinter, T., Vermorken, J. B., Pujade-Lauraine, E., Scartoni, S., Bertolotti, M., Simonelli, C., Capriati, A., Maggi, C. A., Berek, J. S. & Pfisterer, J., 20.04.2013, In: J CLIN ONCOL. 31, 12, p. 1554-61 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Aktuelles zur Diagnostik und Primärtherapie des Ovarialkarzinoms

    Schmalfeldt, B., 2013, Tumorzentrum München Jahrbuch 2013. Schwendt, J. E. & Nüssler, V. (eds.). München: Agileum Verlag und Gesundheitsakademie GmbH

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer

  23. Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer

    Mittermeyer, G., Malinowsky, K., Beese, C., Höfler, H., Schmalfeldt, B., Becker, K-F. & Avril, S., 2013, In: PLOS ONE. 8, 10, p. e77825

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2012

  25. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome

    Avril, S., Hahn, E., Specht, K., Hauptmann, S., Höss, C., Kiechle, M., Höfler, H. & Schmalfeldt, B., 12.2012, In: GYNECOL ONCOL. 127, 3, p. 516-24 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

    Wimberger, P., Gilet, H., Gonschior, A-K., Heiss, M. M., Moehler, M., Oskay-Oezcelik, G., Al-Batran, S-E., Schmalfeldt, B., Schmittel, A., Schulze, E. & Parsons, S. L., 08.2012, In: ANN ONCOL. 23, 8, p. 1979-85 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients

    Steinbach, S., Hundt, W., Schmalfeldt, B., Böhner, C., Berktold, S., Wolf, P. & Harbeck, N., 08.2012, In: ARCH GYNECOL OBSTET. 286, 2, p. 473-80 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV

    Meier, W., du Bois, A., Rau, J., Gropp-Meier, M., Baumann, K., Huober, J., Wollschlaeger, K., Kreienberg, R., Canzler, U., Schmalfeldt, B., Wimberger, P., Richter, B., Schröder, W., Belau, A., Stähle, A., Burges, A. & Sehouli, J., 08.2012, In: GYNECOL ONCOL. 126, 2, p. 236-40 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients

    Seiz, L., Dorn, J., Kotzsch, M., Walch, A., Grebenchtchikov, N. I., Gkazepis, A., Schmalfeldt, B., Kiechle, M., Bayani, J., Diamandis, E. P., Langer, R., Sweep, F. C. G. J., Schmitt, M. & Magdolen, V., 04.2012, In: BIOL CHEM. 393, 5, p. 391-401 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)

    Jäger, M., Schoberth, A., Ruf, P., Hess, J., Hennig, M., Schmalfeldt, B., Wimberger, P., Ströhlein, M., Theissen, B., Heiss, M. M. & Lindhofer, H., 01.01.2012, In: CANCER RES. 72, 1, p. 24-32 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Aktuelles zum Ovarialkarzinom 2011

    Schmalfeldt, B., Seck, K. & Schmalzried, H., 2012, Tumorzentrum München Jahrbuch 2012. Jauch, K. W. & Nüssler, V. (eds.). München: Agileum Verlag und Gesundheitsakademie GmbH

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer

  32. 2011

  33. mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer

    Kotzsch, M., Dorn, J., Doetzer, K., Schmalfeldt, B., Krol, J., Baretton, G., Kiechle, M., Schmitt, M. & Magdolen, V., 11.2011, In: BIOL CHEM. 392, 11, p. 1047-51 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group

    Baumann, K., Pfisterer, J., Wimberger, P., Burchardi, N., Kurzeder, C., du Bois, A., Loibl, S., Sehouli, J., Huober, J., Schmalfeldt, B., Vergote, I., Lück, H. J. & Wagner, U., 10.2011, In: GYNECOL ONCOL. 123, 1, p. 27-32 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer

    Lee, C. K., Friedlander, M., Brown, C., Gebski, V. J., Georgoulopoulos, A., Vergote, I., Pignata, S., Donadello, N., Schmalfeldt, B., Delva, R., Mirza, M. R., Sauthier, P., Pujade-Lauraine, E., Lord, S. J. & Simes, R. J., 07.09.2011, In: JNCI-J NATL CANCER I. 103, 17, p. 1338-42 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Ovarian cancer: diagnosis and treatment

    Burges, A. & Schmalfeldt, B., 09.2011, In: DTSCH ARZTEBL INT. 108, 38, p. 635-41 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer

    Dorn, J., Harbeck, N., Kates, R., Gkazepis, A., Scorilas, A., Soosaipillai, A., Diamandis, E., Kiechle, M., Schmalfeldt, B. & Schmitt, M., 04.2011, In: ANN ONCOL. 22, 4, p. 877-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Das Ovarialkarzinom - Diagnose und Behandlung

    Burges, A. & Schmalfeldt, B., 2011, In: DTSCH ARZTEBL INT. 108, 38, p. 635-41

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  39. Diagnostik und Therapie maligner Ovarialtumoren

    Schmalfeldt, B., 2011, Tumorzentrum München Jahrbuch 2011. Jauch, K. W. & Nüssler, V. (eds.). München: Agileum Verlag und Gesundheitsakademie GmbH

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer › peer-review

  40. Mammakarzinom und Schwangerschaft

    Schmalfeldt, B., Bauerfeind, I., Anthuber, C., Niemeyer, B., Oberlechner, E., Raab, A. & Wolf, C., 2011, Manual Mammakarzinom. Empfehlungen zu Diagnostik, Therapie und Nachsorge.: Tumorzentrum München an den Medizinischen Fakultäten der Ludwig-Maximilian-Universität München und der Technischen Universität München. Janni, W. (ed.). München Wien New York : W. Zuckschwerdt Verlag

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer › peer-review

  41. 2010

  42. Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients

    Hipp, S., Berg, D., Ergin, B., Schuster, T., Hapfelmeier, A., Walch, A., Avril, S., Schmalfeldt, B., Höfler, H. & Becker, K-F., 12.2010, In: VIRCHOWS ARCH. 457, 6, p. 705-13 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Das Mammakarzinom beim Mann: Eine Herausforderung für den Urologen

    Hofer, C., Schmalfeldt, B., Gschwend, J. E. & Herkommer, K., 09.2010, In: UROLOGE. 49, 9, p. 1142, 1144-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Gustatory and olfactory function in breast cancer patients

    Steinbach, S., Hundt, W., Zahnert, T., Berktold, S., Böhner, C., Gottschalk, N., Hamann, M., Kriner, M., Heinrich, P., Schmalfeldt, B. & Harbeck, N., 06.2010, In: SUPPORT CARE CANCER. 18, 6, p. 707-13 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)

    Wimberger, P., Wehling, M., Lehmann, N., Kimmig, R., Schmalfeldt, B., Burges, A., Harter, P., Pfisterer, J. & du Bois, A., 06.2010, In: ANN SURG ONCOL. 17, 6, p. 1642-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Besondere Lebenssituationen (Senium, Schwangerschaftsassoziiertes Mammakarzinom)

    Schmalfeldt, B., 2010, Therapie des Mammakarzinoms. Harbeck N. Unimed Verlag

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  47. Veränderungen und Tumoren der Tuben / Veränderungen und Tumoren des Ovars

    Schmalfeldt, B., 2010, Gynäkologie und Geburtshilfe. Kiechle, M. (ed.). 2 ed. Urban & Fischer

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review

  48. 2009

  49. Subcutaneous mastectomy with conservation of the nipple-areola Skin: broadening the indications

    Paepke, S., Schmid, R., Fleckner, S., Paepke, D., Niemeyer, M., Schmalfeldt, B., Jacobs, V. R. & Kiechle, M., 08.2009, In: ANN SURG. 250, 2, p. 288-92 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis

    Harter, P., Hahmann, M., Lueck, H. J., Poelcher, M., Wimberger, P., Ortmann, O., Canzler, U., Richter, B., Wagner, U., Hasenburg, A., Burges, A., Loibl, S., Meier, W., Huober, J., Fink, D., Schroeder, W., Muenstedt, K., Schmalfeldt, B., Emons, G. & du Bois, A., 05.2009, In: ANN SURG ONCOL. 16, 5, p. 1324-30 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies

    Steinbach, S., Hummel, T., Böhner, C., Berktold, S., Hundt, W., Kriner, M., Heinrich, P., Sommer, H., Hanusch, C., Prechtl, A., Schmidt, B., Bauerfeind, I., Seck, K., Jacobs, V. R., Schmalfeldt, B. & Harbeck, N., 10.04.2009, In: J CLIN ONCOL. 27, 11, p. 1899-905 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany

    Pfisterer, J., Du Bois, A., Bentz, E-K., Kommoss, F., Harter, P., Huober, J., Schmalfeldt, B., Burchardi, N., Arnold, N. & Hilpert, F., 01.2009, In: INT J GYNECOL CANCER. 19, 1, p. 109-15 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Das Ovarialkarzinom aus Sicht des Viszeralchirurgen.

    Pölcher, M., Schmalfeldt, B., Florack, G., Kalff, J. & Kuhn, W., 2009, Viszeralchirurgie. Siewert, J. R., Harder, F. & Rothmund, M. (eds.). Berlin, Heidelberg, New York: Springer, Vol. 2.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  54. Diagnostik und Therapie maligner Ovarialtumoren

    Schmalfeldt, B., 2009, Tumorzentrum München Jahrbuch 2009. München: Agileum Verlag und Gesundheitsakademie GmbH

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer

  55. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up

    Hölscher, G., Anthuber, C., Bastert, G., Burges, A., Mayr, D., Oberlechner, E., Schubert-Fritschle, G., Sinz, S., Sommer, H., Schmalfeldt, B., Engel, J. & 'Malignant Ovarian Tumors' of the Munich Cancer Center (MCC), 2009, In: ACTA OBSTET GYN SCAN. 88, 4, p. 440-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Mammakarzinom und Schwangerschaft

    Schmalfeldt, B., Bauerfeind, I., Anthuber, C., Imhoff, K., Oberlechner, E., Raab, A., Strauss, A. & wOLF, C., 2009, Manual Mammakarzinom. Empfehlungen zu Diagnostik, Therapie und Nachsorge.: Tumorzentrum München an den Medizinischen Fakultäten der Ludwig-Maximilian-Universität München und der Technischen Universität München. Janni, W. (ed.). W. Zuckschwerdt Verlag

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer

  57. Operative Therapie

    Schmalfeldt, B., 2009, Management des Ovarialkarzinoms. Kreienberg, R. (ed.). Springer

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  58. 2008

  59. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group

    Fotopoulou, C., duBois, A., Karavas, A. N., Trappe, R., Aminossadati, B., Schmalfeldt, B., Pfisterer, J., Sehouli, J. & Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR), 01.06.2008, In: J CLIN ONCOL. 26, 16, p. 2683-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next